Literature DB >> 23925273

Longitudinal MR imaging of iron in multiple sclerosis: an imaging marker of disease.

Andrew J Walsh1, Gregg Blevins, R Marc Lebel, Peter Seres, Derek J Emery, Alan H Wilman.   

Abstract

PURPOSE: To investigate the relationship between magnetic resonance (MR) imaging markers of iron content and disease severity in patients with multiple sclerosis (MS) over a 2-year period.
MATERIALS AND METHODS: This prospective study was approved by the local ethics committee, and written informed consent was obtained from all participants. Seventeen patients with MS and 17 control subjects were examined twice, 2 years apart, by using phase imaging and transverse relaxation (R2*) mapping at 4.7 T. Quantitative differences in iron content in deep gray matter between patients and control subjects were evaluated with repeated-measures multivariate analysis of variance separately for R2* mapping and phase imaging. Multiple regression analysis was used to evaluate correlations of MR imaging measures, both 2-year-difference and single-time measurements, to baseline disease severity.
RESULTS: R2* mapping using 2-year-difference measurements had the highest correlation to disease severity (r = 0.905, P < .001) compared with R2* mapping using single-time measurements (r = 0.560, P = .019) and phase imaging by using either single-time (r = 0.539, P = .026) or 2-year-difference (r = 0.644, P = .005) measurements. Significant increases in R2* occur during 2 years in the substantia nigra (P < .001) and globus pallidus (P = .035), which are both predictors of disease in regression analysis, in patients compared with control subjects. There were group differences in the substantia nigra, globus pallidus, pulvinar thalamus, thalamus, and caudate nucleus, compared with control subjects with R2* mapping (P < .05), and group differences in the caudate nucleus and pulvinar thalamus, compared with control subjects with phase imaging (P < .05).
CONCLUSION: There are significant changes in deep gray matter iron content in MS during 2 years measured with MR imaging, changes that are strongly related to physical disability. Longitudinal measurements may produce a higher correlation to disease severity compared with single-time measurements because baseline iron content of deep gray matter is variable among subjects. ©RSNA, 2013.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23925273     DOI: 10.1148/radiol.13130474

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  24 in total

Review 1.  Nonconventional MRI and microstructural cerebral changes in multiple sclerosis.

Authors:  Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas
Journal:  Nat Rev Neurol       Date:  2015-11-03       Impact factor: 42.937

2.  FLAIR2: A Combination of FLAIR and T2 for Improved MS Lesion Detection.

Authors:  V Wiggermann; E Hernández-Torres; A Traboulsee; D K B Li; A Rauscher
Journal:  AJNR Am J Neuroradiol       Date:  2015-10-08       Impact factor: 3.825

3.  Genetic predisposition for inflammation exacerbates effects of striatal iron content on cognitive switching ability in healthy aging.

Authors:  Ana M Daugherty; David A Hoagey; Kristen M Kennedy; Karen M Rodrigue
Journal:  Neuroimage       Date:  2018-10-25       Impact factor: 6.556

4.  Striatal iron content predicts its shrinkage and changes in verbal working memory after two years in healthy adults.

Authors:  Ana M Daugherty; E Mark Haacke; Naftali Raz
Journal:  J Neurosci       Date:  2015-04-29       Impact factor: 6.167

5.  In vivo dentate nucleus MRI relaxometry correlates with previous administration of Gadolinium-based contrast agents.

Authors:  Enrico Tedeschi; Giuseppe Palma; Antonietta Canna; Sirio Cocozza; Carmela Russo; Pasquale Borrelli; Roberta Lanzillo; Valentina Angelini; Emanuela Postiglione; Vincenzo Brescia Morra; Marco Salvatore; Arturo Brunetti; Mario Quarantelli
Journal:  Eur Radiol       Date:  2016-02-23       Impact factor: 5.315

Review 6.  Inflammation in CNS neurodegenerative diseases.

Authors:  Jodie Stephenson; Erik Nutma; Paul van der Valk; Sandra Amor
Journal:  Immunology       Date:  2018-04-17       Impact factor: 7.397

7.  Basal Ganglia Iron in Patients with Multiple Sclerosis Measured with 7T Quantitative Susceptibility Mapping Correlates with Inhibitory Control.

Authors:  P Schmalbrock; R S Prakash; B Schirda; A Janssen; G K Yang; M Russell; M V Knopp; A Boster; J A Nicholas; M Racke; D Pitt
Journal:  AJNR Am J Neuroradiol       Date:  2015-11-26       Impact factor: 3.825

8.  Quantitative Susceptibility Mapping of the Thalamus: Relationships with Thalamic Volume, Total Gray Matter Volume, and T2 Lesion Burden.

Authors:  G C Chiang; J Hu; E Morris; Y Wang; S A Gauthier
Journal:  AJNR Am J Neuroradiol       Date:  2018-01-25       Impact factor: 3.825

Review 9.  Pharmacological MRI (phMRI) of the Human Central Nervous System.

Authors:  H Lanfermann; C Schindler; J Jordan; N Krug; P Raab
Journal:  Clin Neuroradiol       Date:  2015-09-02       Impact factor: 3.649

10.  Accumulation of iron in the putamen predicts its shrinkage in healthy older adults: A multi-occasion longitudinal study.

Authors:  Ana M Daugherty; Naftali Raz
Journal:  Neuroimage       Date:  2015-12-30       Impact factor: 6.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.